Myopathy induced by antimalarial agents: the relevance of screening muscle enzyme levels.
Kalajian
Andrew H
AH
Callen
Jeffrey P
JP
D000328:Adult; D000368:Aged; D000962:Antimalarials / Q000009:adverse effects* / Q000627:therapeutic use; D003402:Creatine Kinase / Q000378:metabolism*; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D005634:Fructose-Bisphosphate Aldolase / Q000378:metabolism*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000201:enzymology*; D009135:Muscular Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000201:enzymology; D011446:Prospective Studies; D012871:Skin Diseases / Q000188:drug therapy*; D011795:Surveys and Questionnaires
D000962:Antimalarials; D007770:L-Lactate Dehydrogenase; D003402:Creatine Kinase; D005634:Fructose-Bisphosphate Aldolase